GFAP mRNA fluctuates in synchrony with chronic relapsing EAE symptoms in SJL/J mice

Glia ◽  
1995 ◽  
Vol 14 (3) ◽  
pp. 216-224 ◽  
Author(s):  
Avinash Kothavale ◽  
David Di Gregorio ◽  
F. Paul Somera ◽  
Marion E. Smith
1983 ◽  
Vol 158 (4) ◽  
pp. 1362-1367 ◽  
Author(s):  
S Sriram ◽  
L Steinman

To test the clinical relevance of monoclonal anti-I-A antibody in autoimmune disease, we investigated the effects of such a therapy in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) by instituting treatment after the onset of paralytic signs and following the clinical course. In chronic relapsing EAE, animals treated with anti-I-As antibody had no mortality and fewer relapses when compared with control animals. Antibody levels to myelin basic protein were lower and histopathology showed milder lesions in the treated group. Similarly, in the acute EAE model, animals treated with anti-I-As antibody showed a dramatic reversal of paralytic signs and a rapid recovery. The mechanisms of action of antibody to IR gene products in autoimmune disease are discussed.


1984 ◽  
Vol 43 (3) ◽  
pp. 327
Author(s):  
G. B. Schuller-Levis ◽  
P. B. Kozlowski ◽  
H. M. Wisniewski

1978 ◽  
Vol 43 (1-2) ◽  
pp. 35-42 ◽  
Author(s):  
H. Lassmann ◽  
H. M. Wisniewski

1988 ◽  
Vol 540 (1 Advances in N) ◽  
pp. 712-714 ◽  
Author(s):  
C. S. RAINE ◽  
R. HINTZEN ◽  
U. TRAUGOTT ◽  
G. R. W. MOORE

2003 ◽  
Vol 136 (1-2) ◽  
pp. 94-103 ◽  
Author(s):  
Annemarie Ledeboer ◽  
Anne Wierinckx ◽  
John G.J.M Bol ◽  
Sarah Floris ◽  
Chantal Renardel de Lavalette ◽  
...  

1994 ◽  
Vol 12 (3) ◽  
pp. 469-475 ◽  
Author(s):  
D. Lanens ◽  
A. Van der Linden ◽  
P.O. Gerrits ◽  
E.J. 's-Gravenmade

Sign in / Sign up

Export Citation Format

Share Document